Skip to main content

Advertisement

Log in

Expression of CD26 and its Association with Dipeptidyl Peptidase IV Activity in Lymphocytes of Type 2 Diabetes Patients

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Immune response and inflammation were suggested to play certain roles in the development and complications of type 2 diabetes mellitus. The main objective of this study was to investigate the CD26 expression and its relationship with adenosine deaminase (ADA), dipeptidyl peptidase IV (DPP-IV), γ-glutamyltransferase (GGT), and N-acetyl-β-glucosaminidase (NAG) activities in lymphocytes of type 2 diabetics (T2DM) patients. These parameters were assessed in 25 T2DM patients and 20 control subjects. We observed a decrease in CD26 expression and a significant increase in the ADA activity in T2DM patients when compared with control subjects. There were no differences between activities of DPP-IV, NAG, and GGT in lymphocytes of T2DM patients and control subjects. Meanwhile, a significant negative correlation was observed between CD26 expression and DPP-IV activity in lymphocytes of T2DM patients. Moreover, a positive correlation was found between DPPIV and ADA activities. The results suggest that the reduction of CD26 expression may be associated in the regulation of DPP-IV in T2DM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 365, 1333–1346.

    Article  PubMed  CAS  Google Scholar 

  2. Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., Halban, P. A., & Ehses, J. A. (2010). Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab, 21, 261–267.

    Article  PubMed  CAS  Google Scholar 

  3. Fernández-Real, J. M., & Pickup, J. C. (2008). Innate immunity, insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism, 19, 10–16.

    Article  PubMed  Google Scholar 

  4. Stentz, F. B., & Kitabchi, A. E. (2005). Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochemical and Biophysical Research Communications, 335, 491–495.

    Article  PubMed  CAS  Google Scholar 

  5. Giordano, C., Stassi, G., Todaro, M., De Maria, R., Richiusa, P., Scorsone, A., et al. (1995). Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-diagnosed IDDM patients. Diabetologia, 38, 953–958.

    Article  PubMed  CAS  Google Scholar 

  6. Greenfield, J. R., & Campbell, L. V. (2006). Relationship between inflammation, insulin resistance and type 2 diabetes: ‘cause or effect’? Current Diabetes Review, 2, 195–211.

    Article  CAS  Google Scholar 

  7. Bühling, F., Junker, U., Reinhold, D., Neubert, K., Jäger, L., & Ansorge, S. (1995). Functional role of CD26 on human B lymphocytes. Immunology Letters, 4, 47–51.

    Article  Google Scholar 

  8. Fleischer, B., Sturm, E., De-Vries, J. E., & Spits, H. (1988). Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. Journal of Immunology, 141, 1103–1107.

    CAS  Google Scholar 

  9. Dinjens, W. N., ten-Kate, J., van-der-Linden, E. P., Wijnen, J. T., Khan, P. M., & Bosman, F. T. (1989). Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. Journal of Histochemistry and Cytochemistry, 37, 1869–1875.

    Article  PubMed  CAS  Google Scholar 

  10. Mentlein, R. (1999). Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides. Regulatory Peptides, 85, 9–24.

    Article  PubMed  CAS  Google Scholar 

  11. Dong, R. P., Kameoka, J., Hegen, M., Tanaka, T., Xu, Y., Schlossman, S. F., et al. (1996). Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. Journal of Immunology, 156, 1349–1355.

    CAS  Google Scholar 

  12. Gorrell, M. D., Gysbers, V., & McCaughan, G. W. (2001). CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scandinavian Journal of Immunology, 54, 249–264.

    Article  PubMed  CAS  Google Scholar 

  13. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993). Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science, 261, 466–469.

    Article  PubMed  CAS  Google Scholar 

  14. Prakash, M. S., Chennaiah, S., Murthy, Y. S. R., Anjaiah, E., Ananda Rao, S., & Suresh, C. (2006). Altered adenosine deaminase activity in type 2 diabetes mellitus. Journal, Indian Academy of Clinical Medicine, 7, 114–117.

    Google Scholar 

  15. Bopp, A., De Bona, K. S., Bellé, L. P., Moresco, R. N., & Moretto, M. B. (2009). Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients. Fundamental and Clinical Pharmacology, 23, 501–507.

    Article  PubMed  CAS  Google Scholar 

  16. Grisk, O., Küster, U., & Ansorge, S. (1993). The activity of gamma-glutamyl transpeptidase (gamma-GT) in populations of mononuclear cells from human peripheral blood. Biological Chemistry Hoppe Seyler, 374, 287–290.

    Article  PubMed  CAS  Google Scholar 

  17. Henson, S. E., Nichols, T. C., Holers, V. M., & Karp, D. R. (1999). The ectoenzyme gamma-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes. Journal of Immunology, 163, 1845–1852.

    CAS  Google Scholar 

  18. André, P., Balkau, B., Born, C., Charles, M. A., Eschwège, E., & D.E.S.I.R. study group. (2006). Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R cohort. Diabetologia, 49, 2599–2603.

    Article  PubMed  Google Scholar 

  19. Wen, J., Liang, Y., Wang, F., Sun, L., Guo, Y., Duan, X., et al. (2010). C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. Clin Chim Acta, 411, 198–203.

    Article  PubMed  CAS  Google Scholar 

  20. Campos, P. P., Bakhle, Y. S., & Andrade, S. P. (2008). Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain. Wound Repair and Regeneration, 16, 416–424.

    Article  PubMed  Google Scholar 

  21. Reiner, R. G., Tanner, A. R., Keyhani, A. H., & Wright, R. (1981). A comparative study of lysosomal enzyme activity in monocytes and Kupffer cells isolated simultaneously in a rat model of liver injury. Clinical and Experimental Immunology, 43, 376–380.

    PubMed  CAS  Google Scholar 

  22. Böyum, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical and Laboratory Investigation, 97, 77–89.

    PubMed  Google Scholar 

  23. Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., et al. (1984). Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. Journal of Immunology, 133, 1250–1256.

    CAS  Google Scholar 

  24. Gorrell, M. D., Wickson, J., & McCaughan, G. W. (1991). Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes. Cellular Immunology, 134, 205–215.

    Article  PubMed  CAS  Google Scholar 

  25. Wrenger, S., Faust, J., Friedrich, D., Hoffmann, T., Hartig, R., Lendeckel, U., et al. (2006). Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function. Journal of Leukocyte Biology, 80, 621–629.

    Article  PubMed  CAS  Google Scholar 

  26. Giusti, G. (1974). Adenosine deaminase. In H. V. Bergmeyer (Ed.), Methods of enzymatic analysis (pp. 1092–1099). New York: Academic Press.

    Google Scholar 

  27. Schön, E., Demuth, H. U., Barth, A., & Ansorge, S. (1984). Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochemical Journal, 223, 255–258.

    PubMed  Google Scholar 

  28. Xavier, D. O., Amaral, L. S., Gomes, M. A., Rocha, M. A., Campos, P. R., Cota, B. D., et al. (2010). Metformin inhibits inflammatory angiogenesis in a murine sponge model. Biomedicine and Pharmacotherapy, 64, 220–225.

    Article  CAS  Google Scholar 

  29. Szasz, G. (1969). Serum cholinesterase. Clinical Chemistry, 15, 124–136.

    PubMed  CAS  Google Scholar 

  30. Bock, O., Kreiselmeyer, I., & Mrowietz, U. (2001). Expression of dipeptidyl-peptidase IV (CD26) on CD8 + T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis. Experimental Dermatology, 10, 414–419.

    Article  PubMed  CAS  Google Scholar 

  31. Wong, P. T., Wong, C. K., Tam, L. S., Li, E. K., Chen, D. P., & Lam, C. W. (2009). Decreased expression of T lymphocyte co-stimulatory molecule CD26 on invariant natural killer T cells in systemic lupus erythematosus. Immunological Investigations, 38, 350–364.

    Article  PubMed  CAS  Google Scholar 

  32. Jeanfavre, D. D., Woska, J. R., Jr., Pargellis, C. A., Kennedy, C. A., Prendergast, J., Stearns, C., et al. (1996). Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase. Biochemical Pharmacology, 52, 1757–1765.

    Article  PubMed  CAS  Google Scholar 

  33. Tan, E. Y., Mujoomdar, M., & Blay, J. (2004). Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior. American Journal of Pathology, 165, 319–330.

    Article  PubMed  CAS  Google Scholar 

  34. Jarmołowska, B., Bielikowicz, K., Iwan, M., Sidor, K., Kostyra, E., & Kaczmarski, M. (2007). Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy. Peptides, 28, 678–682.

    Article  PubMed  Google Scholar 

  35. Schmiedl, A., Krainski, J., Schwichtenhövel, F., Schade, J., Klemann, C., & Raber, K. A., et al. (2010). Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory cells and expression of pulmonary surfactant proteins. Clinical and Experimental Allergy, 40, 1794–1808.

    Google Scholar 

Download references

Acknowledgments

The authors thank the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for the grants, Biotécnica (Varginha, MG, Brazil) for providing biochemical reagents, and Eloisa Sporleder (Laboratório de Imunologia of Santa Casa de Misericórdia of Porto Alegre, RS, Brazil). The first author thanks CAPES (Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) for the scholarship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Beatriz Moretto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellé, L.P., Bitencourt, P.E.R., de Bona, K.S. et al. Expression of CD26 and its Association with Dipeptidyl Peptidase IV Activity in Lymphocytes of Type 2 Diabetes Patients. Cell Biochem Biophys 61, 297–302 (2011). https://doi.org/10.1007/s12013-011-9212-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-011-9212-6

Keywords

Navigation